106 related articles for article (PubMed ID: 11219112)
1. [Drug therapy of heart insufficiency guided by hormone measurements].
Kjaer A; Haunsø S
Ugeskr Laeger; 2001 Jan; 163(3):304. PubMed ID: 11219112
[No Abstract] [Full Text] [Related]
2. Natriuretic peptide-guided therapy for heart failure: ready for "battle" or too "scarred" by the challenges of trial design?
Maisel A
J Am Coll Cardiol; 2009 Dec; 55(1):61-4. PubMed ID: 20117365
[No Abstract] [Full Text] [Related]
3. Biomarker-guided therapy in chronic heart failure: a meta-analysis of randomized controlled trials.
Felker GM; Hasselblad V; Hernandez AF; O'Connor CM
Am Heart J; 2009 Sep; 158(3):422-30. PubMed ID: 19699866
[TBL] [Abstract][Full Text] [Related]
4. [Better treatment of heart failure by measurements of natriuretic peptides. There are still remaining problems when it comes to the interpretation of measurement levels].
Lindstedt G; Dahlström U; Fernlund P; Schaufelberger M; Stridsberg M
Lakartidningen; 2001 Oct; 98(41):4444-8, 4450-2. PubMed ID: 11699251
[TBL] [Abstract][Full Text] [Related]
5. Biomarker-guided treatment of heart failure: still waiting for a definitive answer.
Troughton RW; Frampton CM; Nicholls MG
J Am Coll Cardiol; 2010 Dec; 56(25):2101-4. PubMed ID: 21144970
[No Abstract] [Full Text] [Related]
6. [Plasma brain natriuretic peptide levels in the diagnostic and prognostic assessment of patients with heart failure. Cons].
Andreuzzi B; Mangiavacchi M; Pini D; Municinò A; Genovese L; Tomaello L; Gronda E
Ital Heart J; 2003 Dec; 4 Suppl 8():68S-72S. PubMed ID: 15005535
[No Abstract] [Full Text] [Related]
7. [Plasma brain natriuretic peptide levels in the diagnostic and prognostic assessment of patients with heart failure. Pros].
Metra M; Nodari S; Pedrinazzi C; Rocca P; Manerba A; Vizzardi E; Danesi R; Dei Cas L
Ital Heart J; 2003 Dec; 4 Suppl 8():59S-67S. PubMed ID: 15005534
[No Abstract] [Full Text] [Related]
8. Can natriuretic peptides help identify heart failure patients for whom statins are beneficial?
Daniels LB; Barrett-Connor E
J Am Coll Cardiol; 2009 Nov; 54(20):1860-1. PubMed ID: 19892236
[No Abstract] [Full Text] [Related]
9. Brain natriuretic peptide in heart failure and beyond.
Mowla MM; Bustami BB
Saudi Med J; 2006 Oct; 27(10):1457-61. PubMed ID: 17013463
[TBL] [Abstract][Full Text] [Related]
10. Testing new targets of therapy in advanced heart failure: the design and rationale of the Strategies for Tailoring Advanced Heart Failure Regimens in the Outpatient Setting: BRain NatrIuretic Peptide Versus the Clinical CongesTion ScorE (STARBRITE) trial.
Shah MR; Claise KA; Bowers MT; Bhapkar M; Little J; Nohria A; Gaulden LH; McKee VK; Cozart KL; Mancinelli KL; Daniels H; Kinard T; Stevenson LW; Mancini DM; O'Connor CM; Califf RM
Am Heart J; 2005 Nov; 150(5):893-8. PubMed ID: 16290955
[No Abstract] [Full Text] [Related]
11. B-type natriuretic peptide in heart failure.
Moe GW
Curr Opin Cardiol; 2006 May; 21(3):208-14. PubMed ID: 16601459
[TBL] [Abstract][Full Text] [Related]
12. Plasma brain natriuretic peptide-guided therapy not yet justified.
Hoppe UC
J Am Coll Cardiol; 2007 Nov; 50(21):2097-8; author reply 2098-9. PubMed ID: 18021882
[No Abstract] [Full Text] [Related]
13. Brain natriuretic peptide is unchanged after 4 weeks of continuous positive airway pressure therapy.
Pepperell J; Stradling J; Davies R
J Sleep Res; 2006 Dec; 15(4):463-4. PubMed ID: 17118104
[No Abstract] [Full Text] [Related]
14. Serial monitoring of brain natriuretic peptide concentrations for drug therapy management in patients with chronic heart failure.
Gallegos PJ; Maclaughlin EJ; Haase KK
Pharmacotherapy; 2008 Mar; 28(3):343-55. PubMed ID: 18294114
[TBL] [Abstract][Full Text] [Related]
15. [Recommendations for the clinical use of cardiac natriuretic peptides].
Emdin M; Clerico A; Clemenza F; Galvani M; Latini R; Masson S; Mulè P; Panteghini M; Valle R; Zaninotto M; Ganau A; Mariotti R; Volpe M; Aspromonte N; Cacciatore G; Cappelletti P; L'Abbate A; Miglio F; Ottani F; Pagani F; Passino C; Plebani M; Sarzani R; Zucchelli G
Ital Heart J Suppl; 2005 May; 6(5):308-25. PubMed ID: 15934430
[No Abstract] [Full Text] [Related]
16. Diagnostic and therapeutic utility of B-type natriuretic peptide in patients with renal insufficiency and decompensated heart failure.
McCullough PA; Kuncheria J; Mathur VS
Rev Cardiovasc Med; 2003; 4 Suppl 7():S3-S12. PubMed ID: 14668695
[TBL] [Abstract][Full Text] [Related]
17. Interpretation of amino-terminal pro-brain natriuretic peptide levels in the HPS and the CORONA study.
Cleland JG; Squire I; Ng L
J Am Coll Cardiol; 2008 Sep; 52(13):1104-5. PubMed ID: 18848145
[No Abstract] [Full Text] [Related]
18. Natriuretic peptides in patients with atrial fibrillation and advanced chronic heart failure: determinants and prognostic value of (NT-)ANP and (NT-pro) BNP.
Shelton RJ; Goode K; Cleland JG
Europace; 2007 Feb; 9(2):147; author reply 148. PubMed ID: 17227813
[No Abstract] [Full Text] [Related]
19. [Consensus document. Type B natriuretic peptide in the Italian cardiology clinical reality: update of the experience].
Ital Heart J Suppl; 2003 Oct; 4(10):850-61. PubMed ID: 14664297
[TBL] [Abstract][Full Text] [Related]
20. [Monitoring heart failure with brain natriuretic peptide].
Sela B
Harefuah; 2003 Jan; 142(1):25-31, 78. PubMed ID: 12647486
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
